Art

J-GLOBAL ID：201902239056143438   Reference number：19A2755688

Difference in Acquired Radioresistance Induction Between Repeated Photon and Particle Irradiation

反復光子と粒子照射の間の後天的放射線抵抗誘導における差異【JST・京大機械翻訳】

Author (3)： Sato Katsutoshi (Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, United States) ,  Shimokawa Takashi (Department of Accelerator and Medical Physics, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology, Chiba, Japan) ,  Imai Takashi (Medical Databank, Department of Radiation Medicine, QST Hospital, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)
Material： Frontiers in Oncology (Web)
Volume： 9  Page： 1213  Publication year： 2019 
JST Material Number： U7089A  ISSN： 2234-943X  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： In recent years, advanced radi...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2755688&from=J-GLOBAL&jstjournalNo=U7089A") }}

Thesaurus term： therapy ,  excision ,  Phenotype ,  radiation resistance (radiation effect) ,  Radiotherapy ,  orientation (organism) ,  in vitro experiment ,  treatment outcome ,  X-ray irradiation ,  human ,  tumor cell ,  *photon ,  X-ray ,  *radioactive ray ,  molecular mechanism ,  carbon ion

Author keywords (8)： cancer ,  radioresistance ,  acquisition ,  X-ray radiation ,  carbon-ion radiation ,  repeated irradiation ,  DNA repair ,  aggressiveness

JST classification (2)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Cell physiology in general  (EF02010S)

Reference (94)：

• Ohnishi H, Shirato H, Nagata Y, Hiraolka M, Fujino M, Gomi K, et al. Hypofractinated stereoptactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japnese multi-institutional study. J Thorac Oncol. (2007) 2:S94-100. doi: 10.1097/JTO.0b013e318074de34
• Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, et al. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol. (2014) 53:399-404. doi: 10.3109/0284186X.2013.820342
• Freeman DE, King CR. Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radio Oncol. (2011) 6:3. doi: 10.1186/1748-717X-6-3
• Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, et al. Clinical outcomes of stereotactic body radiotherapy for patients with stage I small-cell lung cancer: analysis of a subset of the Japanese radiological society multi-institutional SBRT study group database. Technol Cancer Res Treat. (2018). 17:1533033818783904. doi: 10.1177/1533033818783904
• Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof EM, Van Vulpen M, et al. Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection. Anticancer Res. (2015) 35:5607-14. doi: 10.1177/1533033818783904

Terms in the title (5)： 反復 ,  光子 ,  放射線 ,  誘導 ,  差異